Federal funding could further boost Treatment.com AI’s healthcare initiatives
Treatment is bringing AI to the the next generation of healthcare professionals, supporting medical and nursing schools, who use its Global Library of Medicine to enhance future clinical skills of their students. As a Canadian company using AI to positively disrupt the healthcare sector, Treatment welcomed the recent news of a federal government plan […]
Treatment.com AI announces new additions to its Medical Education Suite (MES)
VANCOUVER, British Columbia, April 17, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is excited to announce two new solutions, (1) AI Patient and (2) AI Doctor in a Pocket, to augment its Medical Education Suite (“MES”) designed to educate the next generation of healthcare providers. Treatment’s MES […]
Treatment.com AI partners with aiXplain Inc. to extend access to its Global Library of Medicine (GLM)
VANCOUVER, British Columbia, April 10, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (“Treatment”) is pleased to announce it has signed a Collaborative Agreement with aiXplain, Inc. (“aiXplain”) to enable greater access to Treatment’s proprietary Global Library of Medicine (“GLM”) by contributing to aiXplain’s ever-growing dynamic Artificial Intelligence (AI) marketplace. Treatment has […]
Treatment.com AI welcomes the Federal Government’s announcement of a plan to fund $2.4 billion in its upcoming budget towards Artificial Intelligence (AI) Adoption
VANCOUVER, British Columbia, April 08, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) welcomes Prime Minister Justin Trudeau’s announcement on 7th April, 2024, that the federal government plans to fund $2.4 billion in its upcoming budget towards build capacity in Artificial Intelligence (AI) adoption. The federal government’s announcement […]
Treatment.com AI Funded by the National Institute of Health to Develop a Culturally Sensitive AI Approach to Health Equity
VANCOUVER, British Columbia, March 27, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that the Company has received funding from The National Institute of Health (“NIH”) to develop a culturally sensitive AI approach for collecting family medical history. Treatment has partnered with Rush River […]
Treatment.com AI inc. Announces Debt Settlement Transactions
Vancouver, British Columbia, March 21, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) announces that it proposes to enter into debt settlement agreements with certain arms’ length creditors (the “Creditors”) to settle an aggregate of CAD$461,307.40 in debt (the “Debt”). The Debt relates to outstanding principal and accrued interest on […]
Treatment AI Passes Medical School Clinical Exam with 92% Success Rate
VANCOUVER, British Columbia, March 20, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to announce that it’s AI medical information support platform was used in the “Objective Structured Clinical Examination” (“OSCE”), a standard clinical exam of diagnostic aptitude at medical and nursing schools, passing the exam […]
Treatment.com AI Inc. Closes over-subscribed non-brokered private placement of $2,908,200
Vancouver, British Columbia, March 14, 2024 – Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce that, further to its news release dated February 16, 2024, it has closed a non-brokered private placement of 6,295,500 special warrants of the Company (each, a “Special Warrant”) at a price of $0.40 […]
Treatment.com AI Provides Corporate Update
Bolstering the Leadership Team The Global Library of Medicine Passes Milestone of 1000+ Diseases Treatment Provides Platform to Support Healthcare in Nairobi, Kenya VANCOUVER, British Columbia, February 29, 2024 – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) (the “Company” or “Treatment”) is pleased to provide a general corporate update. Treatment has been working […]
Treatment.Com International Inc. Announces Closing Of Non-Brokered Private Placement
Vancouver, British Columbia, October 5, 2023 – Treatment.com International Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; FFA: 939) is pleased to announce, further to its news release on September 28, 2023, the Company has completed its previously announced non-brokered private placement of common shares in the capital of the Company (each, a “Common Share”) at […]